Amit Shapira1, Kara R Harrington1, Eveline R Goethals1,2,3, Lisa K Volkening1, Lori M Laffel1. 1. Section on Clinical, Behavioral, and Outcomes Research, Pediatric, Adolescent, and Young Adult Section, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. 2. Vanderbilt University Medical Center, Nashville, TN, USA. 3. KU Leuven, Leuven, Belgium.
Abstract
AIM: This cross-sectional study examined the associations of comorbid conditions on health-related quality of life (HRQOL) in 601 youth with type 1 diabetes. We evaluated associations between number of comorbid conditions (0, 1, ≥2) and particular comorbid conditions and youth HRQOL by self-report and parent proxy-report. RESEARCH DESIGN AND METHODS: Youth with type 1 diabetes, aged 5-18 years, and their parents completed the PedsQL 4.0 Generic Core Scales self-report and parent proxy-report, respectively; they also reported youths' comorbid medical and mental health conditions. Separate linear regression models tested the relationship between number of comorbid conditions and specific comorbid conditions with youth-reported and parent proxy-reported HRQOL. RESULTS: Youth with ≥2 comorbid conditions had significantly lower HRQOL by both self- and parent proxy-reports compared with youth with 0 or 1 comorbid condition (youth self-report: 0: 85 ± 12, 1: 85 ± 13, 2+: 78 ± 16, p = <0.0001; parent proxy-report: 0: 83 ± 12, 1: 81 ± 13, 2+: 74 ± 15, p = <0.0001). Amongst the comorbid conditions, only a mental health comorbidity was associated with lower HRQOL. For youth and parent proxy-reports, both the number of comorbidities (≥2) and the presence of a mental health comorbidity were significantly associated with lower HRQOL. CONCLUSIONS: Health-related quality of life seems to be preserved in youth with type 1 diabetes unless confronted by multiple comorbidities as reported by youth and their parents. Our findings highlight the importance of tracking the presence of multiple comorbid conditions, possibly by reviewing problem and medication lists in the medical record, as well as screening for and addressing mental health conditions in routine diabetes care.
AIM: This cross-sectional study examined the associations of comorbid conditions on health-related quality of life (HRQOL) in 601 youth with type 1 diabetes. We evaluated associations between number of comorbid conditions (0, 1, ≥2) and particular comorbid conditions and youth HRQOL by self-report and parent proxy-report. RESEARCH DESIGN AND METHODS: Youth with type 1 diabetes, aged 5-18 years, and their parents completed the PedsQL 4.0 Generic Core Scales self-report and parent proxy-report, respectively; they also reported youths' comorbid medical and mental health conditions. Separate linear regression models tested the relationship between number of comorbid conditions and specific comorbid conditions with youth-reported and parent proxy-reported HRQOL. RESULTS: Youth with ≥2 comorbid conditions had significantly lower HRQOL by both self- and parent proxy-reports compared with youth with 0 or 1 comorbid condition (youth self-report: 0: 85 ± 12, 1: 85 ± 13, 2+: 78 ± 16, p = <0.0001; parent proxy-report: 0: 83 ± 12, 1: 81 ± 13, 2+: 74 ± 15, p = <0.0001). Amongst the comorbid conditions, only a mental health comorbidity was associated with lower HRQOL. For youth and parent proxy-reports, both the number of comorbidities (≥2) and the presence of a mental health comorbidity were significantly associated with lower HRQOL. CONCLUSIONS: Health-related quality of life seems to be preserved in youth with type 1 diabetes unless confronted by multiple comorbidities as reported by youth and their parents. Our findings highlight the importance of tracking the presence of multiple comorbid conditions, possibly by reviewing problem and medication lists in the medical record, as well as screening for and addressing mental health conditions in routine diabetes care.
Authors: C Nederstigt; B S Uitbeijerse; L G M Janssen; E P M Corssmit; E J P de Koning; O M Dekkers Journal: Eur J Endocrinol Date: 2019-02-01 Impact factor: 6.664
Authors: Alan M Delamater; Maartje de Wit; Vincent McDarby; Jamil A Malik; Marisa E Hilliard; Elisabeth Northam; Carlo L Acerini Journal: Pediatr Diabetes Date: 2018-10 Impact factor: 4.866
Authors: Jean M Lawrence; Joyce P Yi-Frazier; Mary Helen Black; Andrea Anderson; Korey Hood; Giuseppina Imperatore; Georgeanna J Klingensmith; Michelle Naughton; Elizabeth J Mayer-Davis; Michael Seid Journal: J Pediatr Date: 2012-02-22 Impact factor: 4.406
Authors: Katherine Semenkovich; Kristoffer S Berlin; Rachel L Ankney; Kimberly L Klages; Mary E Keenan; Tiffany M Rybak; Gabrielle G Banks; Ramin Alemzadeh; Angelica Eddington Journal: Health Psychol Date: 2019-04-11 Impact factor: 4.267
Authors: A Kozhakhmetova; R C Wyatt; C Caygill; C Williams; A E Long; K Chandler; R J Aitken; J M Wenzlau; H W Davidson; K M Gillespie; A J K Williams Journal: Clin Exp Immunol Date: 2018-03-24 Impact factor: 4.330
Authors: Barbara J Anderson; Lori M Laffel; Catherine Domenger; Thomas Danne; Moshe Phillip; Carmen Mazza; Ragnar Hanas; Sheridan Waldron; Roy W Beck; Francoise Calvi-Gries; Chantal Mathieu Journal: Diabetes Care Date: 2017-05-25 Impact factor: 19.112
Authors: Dayna E McGill; Lisa K Volkening; Deborah A Butler; Kara R Harrington; Michelle L Katz; Lori M Laffel Journal: Diabetes Technol Ther Date: 2018-05-04 Impact factor: 6.118
Authors: Oana P Zaharia; Stefanie Lanzinger; Joachim Rosenbauer; Wolfram Karges; Karsten Müssig; Sebastian M Meyhöfer; Volker Burkart; Michael Hummel; Dirk Raddatz; Michael Roden; Julia Szendroedi; Reinhard W Holl Journal: Front Endocrinol (Lausanne) Date: 2022-06-03 Impact factor: 6.055